Am J Transplant, Volume 19, Suppl 3 Archives - Page 196 of 214 - ATC Abstracts

2019 American Transplant Congress
Comparison of Tacrolimus or Cyclosporine Combined with Methotrexate for Graft versus Host Disease Prophylaxis after Allogeneic Hematopoietic Cell Transplantation: A Meta-Analysis
M. Chen, B. Huang, Y. Zhang, W. Ju, X. He
Transplant Center, Sun Yat-sen University, Guangzhou, China
*Purpose: After patients received hematopoietic stem cell transplantation (HSCT) ,both cyclosporine (CsA) and tacrolimus (TAC) in combination with methotrexate (MTX) have been recommended as standard…
2019 American Transplant Congress
mTOR Inhibitors Enhance Antitumor Activity of Liver Resident NK Cells
J. Saparbay, Y. Tanaka, A. Seidakhmetov, H. Ohdan
Gastroenterology and transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: The immunosuppressive regimen currently used after organ transplantation reduces adaptive components. Therefore, the innate immune cells play pivotal roles in immune surveillance and defense…
2019 American Transplant Congress
Endothelial Cells Do Not Regulate Expression of CD46, CD55 and CD59 in the Presence of Anti-HLA Class I and 11 Antibodies
A. Babu¹, T. Pham², M. Hamdorf², V. Jucaud², M. Everly², S. Daga³, D. Mitchell⁴
¹Transplant Institute, Henry Ford Hospitals, Detroit, MI, ²Terasaki Research Institute, Los Angeles, CA, ³University of Warwick, Coventry, United Kingdom, ⁴Medical Sciences, University of Warwick, Coventry, United Kingdom
*Purpose: Anti-HLA antibodies, both pre-formed and de novo are associated with worse graft survival. Complement activation is an important mechanism of antibody mediated immunological injury.…
2019 American Transplant Congress
Living Kidney Donor Time Zero Biopsy Findings Predict Graft Loss in the Recipient
N. Issa¹, C. Lopez¹, A. Denic¹, J. J. Larson¹, R. Narasimhan¹, L. Archila¹, S. S. Taler¹, H. Chakkera², J. Augustine³, M. Stegall⁴, A. Rule¹
¹Nephrology, Mayo Clinic, Rochester, MN, ²Nephrology, Mayo Clinic, Phoenix, AZ, ³Nephrology, Cleveland Clinic, Cleveland, OH, ⁴Transplantation, Mayo Clinic, Rochester, MN
*Purpose: Recipient outcomes with living donor kidney grafts are superior to those achieved from deceased donors. However, there may still be variability in the quality…
2019 American Transplant Congress
The Safety Of Adjuvant Chemotherapy In Kidney Transplant Patients With Urothelial Carcinoma
Z. Wang, J. Xiao, Y. Zhu, J. Lin, Y. Guo, Y. Tian
Capital Medical University，Beijing Friendship Hospital, Beijing, China
*Purpose: The purpose of the present study was to evaluate the safety of adjuvant chemotherapy with gemcitabine plus cisplatin in kidney transplant patients with urothelial…
2019 American Transplant Congress
Impact of Acute Kidney Injury in Elderly Deceased Donor on the Post-Transplant Clinical Outcomes
J. Kim¹, J. Lee², Y. Kim³, K. Jin⁴, S. Han⁴, Y. Hong¹, Y. Chang¹, S. Kim¹, H. Yoon⁵, C. Yang², W. Park⁴, B. Chung²
¹Internal Medicine, Daejeon St. Mary`s Hospital, Daejeon, Korea, Republic of, ²Internal Medicine, Seoul St. Mary`s Hospital, Seoul, Korea, Republic of, ³Internal Medicine, Uijeongbu St. Mary`s Hospital, Uijeongbu, Korea, Republic of, ⁴Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of, ⁵Internal Medicine, Incheon St. Mary`s Hospital, Incheon, Korea, Republic of
*Purpose: The proportion of kidney transplantation (KT) from deceased donors (DDs) with acute kidney injury (AKI) or aged more than 60 has increased, but it…
2019 American Transplant Congress
A Retrospective Matched Case-Control Study of Medical and Psychiatric Outcomes in Kidney Transplant Recipients with Bipolar Disorder
A. GOSWAMI BANERJEE¹, S. Hamel², R. Weinrieb¹, S. Dave¹, V. Johnson³, D. Sawinski⁴, J. Trofe-Clark³
¹Psychiatry, Univ. of Pennsylvania, Philadelphia, PA, ²Vanderbilt Univ. Medical Center, Nashville, TN, ³Pharmacy, Hospital of the Univ. of Pennsylvania, Philadelphia, PA, ⁴Renal, Univ. of Pennsylvania, Philadelphia, PA
*Purpose: Management of kidney transplant recipients (KTRs) with bipolar disorder (BD) is complicated by risk factors for non-adherence, complex medication regimens and limited published guidance.…
2019 American Transplant Congress
Capturing Stories about Living Kidney Donation Using Storytelling Capture Technology: A Feasibility Assessment
A. D. Waterman¹, C. S. Anderson¹, O. N. Ranasinghe¹, Y. Cui², S. Brecher¹, W. Balliet³
¹Division of Nephrology, UCLA School of Medicine, Los Angeles, CA, ²Terasaki Research Institute, Los Angeles, CA, ³Division of Bio-behavioral Medicine, Medical University of South Carolina, Charleston, SC
*Purpose: Humans are storytelling beings. Hearing real-life stories about living donor kidney transplant (LDKT) can motivate and educate others about living donation including its risks…
2019 American Transplant Congress
Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast Enhanced Ultrasonography
C. Yang¹, T. Zhu¹, W. He²
¹Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China, ²Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai, China
*Purpose: To evaluated the application of contrast enhanced ultrasonography (CEUS) in diagnosis of renal allograft chronic rejection (CR).*Methods: Sixty-six renal transplantation recipients were enrolled in…
2019 American Transplant Congress
Severe Acute Rejection In Human Leukocyte Antigen Identical Renal Transplants: Reviving Mixed Lymphocyte Culture
P. Rajendran¹, M. Cusick², S. Dhingra³, B. Murthy¹
¹Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ³Pathology, Baylor College of Medicine, Houston, TX
*Purpose: Human leukocyte antigen-identical renal transplants among siblings account for a minority of all renal transplants, but have excellent long-term outcomes due to very minimal…